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Abstract
Background: Depression is a common and recurrent condition among older adults and is associated with poor
quality of life and increased health care utilization and costs. The purpose of this pilot study was to assess the
feasibility of delivering a psychosocial intervention targeting depression, and to develop the procedures to conduct
a cluster randomized controlled trial among older adults registered with primary care clinics in poor
neighbourhoods of São Paulo, Brazil.
Methods: We conducted a pilot study of a two-arm cluster, non-randomized controlled trial. Two primary care
clinics adhering to the Family Health Strategy were allocated to either the intervention or the control arm. In the
control arm, patients received enhanced usual care consisting of staff training for improved recognition and
management of depression. In the intervention arm, alongside the enhanced usual care, patients received a 17-
week psychosocial intervention delivered by health workers assisted with an application installed in a tablet.
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Results: We randomly selected 579 of 2020 older adults registered in the intervention clinic to participate in the
study. Among these individuals, 353 were assessed for depression and 40 (11.0%) scored at least 10 on the PHQ-9
and were therefore invited to participate. The consent rate was 33/40 (82%) with a resulting yield of 33/579 (5.7%).
In the control arm, we randomly selected 320 older adults among 1482 registered in the clinic, 223 were assessed
for depression and 28 (12.6%) scored 10 or above on the PHQ-9. The consent rate was 25/28 (89%), with a resulting
yield of 25/320 (7.8%). Of the 33 who consented in the intervention arm, 19 (59.4%) completed all sessions. The
mean PHQ-9 at follow-up (approximately 30 weeks after inclusion) were 12.3 (SD = 3.7) and 3.8 (SD = 3.9) in the
control and intervention arms, respectively. Follow-up rates were 92 and 94% in control and intervention arms,
respectively.
Conclusions: Identification and engagement of clinics, randomization, recruitment of individuals, measures, and
baseline and follow-up assessments all proved to be feasible in primary care clinics in São Paulo, Brazil. Results
support the development of a definitive cluster randomized controlled trial.
Trial registration: This study was retrospectively registered with Registro Brasileiro de Ensaios Clínicos (ReBEC),
number RBR-5nf6wd. Registered 06 August 2018.
Keywords: Older adults, Depression, Pilot study, Primary care, Collaborative care
Background
Most Low-Middle-Income Countries (LMIC) are experi-
encing a rapid growth of their ageing populations.
According to the latest population census, Brazil has ap-
proximately 20 million people aged over 60 years (11%
of the population), most of whom live in poverty and
isolation [1], and it is expected that there will be 73.5
million older adults in 2060. Depression is a common
chronic condition among older adults [2–5] and is asso-
ciated with poor quality of life [6, 7], adverse social and
health events [8–10], and increased health care
utilization and costs [11, 12].
Health care systems in LMIC are not well prepared
to meet the mental health challenges associated with
these population changes. Unsurprisingly, depression
in later life often goes unrecognized and untreated
[13–16]. A survey of older adults living in poor
neighbourhoods in São Paulo, Brazil, found that less
than 5% of cases of depression were identified by
Family Health Teams (primary care services), and that
among those identified with depression, only 12.3%
were receiving treatment [17].
The most effective treatments for depression in later life
have been developed and tested in high-income countries
[18–20]. These are complex, multiple component inter-
ventions delivered in primary care, with several health
workers simultaneously collaborating on delivering a care
plan (collaborative model). Resources in these pro-
grammes are allocated according to the specific needs of
the patient (hence, stepped-care model). Although there is
evidence from high-income countries of effective treat-
ments for depression in later life, generalizing from this
evidence to LMIC is problematic given socio-cultural and
health system differences. The World Health Organization
recommends that the treatment of depression should be
delivered predominantly in primary care [21, 22]. The in-
tegration of mental health care into primary care is still far
from adequate in Brazil and most other LMIC, where suc-
cessful depression programmes based on collaborative
care models are hard to find.
Simple, feasible, and affordable primary care interven-
tions aimed at treating depression in older adults are
therefore needed in Brazil and other LMIC experiencing
similar demographic transitions [23]. These interven-
tions should target the main barriers to treat depression
in these settings, such as: patients’ social isolation and
mobility problems; health workers’ difficulty in identify-
ing depressive symptoms and lack of skills and support
needed to deliver effective interventions; poor coordin-
ation, continuity of care and accountability within health
teams; scarcity of resources; and unavailability of special-
ized mental health care [13–16, 24]. Such interventions
should be developed and piloted thoroughly before being
subject to definitive evaluations.
We therefore developed and evaluated the feasibility of
a collaborative care depression programme for depressed
older adults with strong community-based and task-
shifting [25] components customized to the existing Bra-
zilian primary care setting. In this paper, we present the
results of a two-arm, non-randomized controlled cluster
study aimed at evaluating the feasibility of the interven-
tion and of a future randomised controlled trial to test
its effectiveness. The cluster design was chosen to avoid
contamination, as community health workers respon-
sible for delivering the psychosocial intervention could
be employed across clusters. This pilot study provides
an important opportunity to identify potential difficulties
and challenges and the necessary refinements of our re-
search procedures, before we conduct the definitive clus-
ter randomized controlled trial (RCT) to investigate the
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cost-effectiveness of the collaborative care programme
for late life depression.
Aims
1. To assess the feasibility of recruitment, assessments
and random selection of participants in each clinic.
2. To obtain an estimate of the variability of the
outcome across clinics and recruitment/retention
rates to inform sample size calculations for a
definitive RCT.
3. To evaluate the feasibility of delivering the
psychosocial intervention, and to compare the
performance of various health workers delivering
the intervention.
4. To assess the feasibility of collecting information on
use of resources, including costs associated with
intervention delivery, and health data from existing
health system databases, to conduct an economic
evaluation during the definitive trial.
Methods
This is a two-arm pilot study of a non-randomized, con-
trolled cluster trial.
Study setting
The study was conducted in primary care clinics adher-
ing to the Family Health Strategy (FHS) [26] in São
Paulo, Brazil. Each clinic provides comprehensive and
continuous care for inhabitants from a defined catch-
ment area. Health professionals within the clinic work in
Family Health Teams (FHT). Each team is responsible
for up to 4000 inhabitants. In 2017, there were 42,105
FHTs deployed across the country providing health
cover to 130,487,012 Brazilians, approximately 63% of
the population [27]. Two clinics located in Northern São
Paulo were invited to participate in the study. The man-
agers of these clinics agreed participation in the pilot
study. It was decided a priori that the first clinic to
accept participation would become the intervention arm.
This clinic had seven FHTs, whilst the control clinic had
three FHTs. In both arms, the FHTs comprised a family
doctor, one nurse, two NAs, and six CHWs. Both NAs
and CHWs must have completed secondary education,
but NAs need to successfully complete an additional
nursing technical course of one-year duration. CHWs,
on the other hand, learn their skills through hands-on
experience and continuous education. CHWs are also
required to be residents in the catchment area for that
clinic.
Participants
Eligible participants were individuals aged 60 years and
older registered with the two participating clinics. The
exclusion criteria were: Patient Health Questionnaire-928
(PHQ-9) score < 10; complete deafness; terminal illness;
risk of suicide; or an inability to communicate (e.g., due
to cognitive impairment either reported by a family
member or detected by the researcher). The exclusion
criteria were checked by the research assistants during
recruitment and baseline assessments.
Assessments
Recruitment
All CHWs at the intervention and control clinics were
asked to provide a list with all their patients aged 60 years
or older. From those lists, a random sample of potential
participants was selected for the recruitment interview,
through computer generated numbers which were man-
aged by a research assistant unaware of the clinic’s alloca-
tion. All interviews were carried out either by phone or
home visits by trained research assistants blinded to partici-
pants’ allocation. All questionnaires were read out to partic-
ipants. The research team tried to contact by phone each of
the sampled participants three times. If phone calls were
not successful after the third attempt, the research team
made three attempts to visit the potential participant at
home. During recruitment, information on participants’
education, income, and job status was gathered. The assess-
ment of depression (primary outcome) was conducted with
the PHQ-9 [28]. The PHQ-9 is a well-validated brief de-
pression measure extensively used in primary care and clin-
ical research in a large number of countries, including
Brazil [29], which is sensitive to changes over time [30, 31].
The PHQ-9 comprises nine questions, each one rated from
0 (not at all) to 3 (all the time).
Baseline
All participants who scored at least 10 in the PHQ-9 (cut-
off point for depression) at recruitment were approached
for a face-to-face assessment at home. This assessment
was carried out as soon as possible after recruitment. If
the baseline assessment was performed more than 28 days
after recruitment, the PHQ-9 was repeated. This proced-
ure was needed for 42 participants, with 11 of them scor-
ing < 10 in the second PHQ-9, resulting in the exclusion
and replacement of these individuals. During the baseline
assessment, the following information was gathered: 1)
Sociodemographic information including gender, city/
state/country of origin, race, marital status, socioeconomic
status, religious activities. 2) General health status was
assessed using self-reported history of hypertension, dia-
betes, cancer, and stroke. 3) Quality of life was assessed
with the European Quality of Life 5 Dimensions-5 levels
version (EQ-5D-5 L) [32]. 4) Capability of older people
with the Investigating Choice Experiments for the Prefer-
ences of Older People-CAPability (ICECAP-O) [33, 34].
and physical disability (use of cane, wheel chair, diapers,
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and being bedridden). 5) Social support and stressful life
events [35]. 6) Consumption of alcohol (Alcohol Use Dis-
orders Identification Test - AUDIT) [36] and tobacco.
The treatment started approximately 2 weeks after base-
line assessment was carried out.
Written informed consent was gained from all partici-
pants for the recruitment and baseline interviews.
Follow-up
Follow-up assessment took place approximately 4 weeks
after the end of the intervention (26 to 32 weeks after
baseline PHQ-9). It consisted of a face-to-face interview
at the participant’s home carried out by an independent
trained research assistant. Quality of life (EQ5D-5 L),
capability (ICECAP-O), and stressful life events were re-
assessed at follow-up. New measures included at follow-
up were a 5-item Likert visual analogue scale to provide
a self-assessment of mood (5 faces), and an economic as-
sessment that included utilization of private care, need
for care, purchase of mental health medication, oppor-
tunity costs related to the disease (measured by the time
spent on disease-related activities), and work productiv-
ity measures. Opportunity costs measure the alternative
use of time and can be monetized by considering how
individuals value time (usually the monetary value of
time is the individual’s work productivity measure, such
as their salary or pension per unit of time).
Intervention costs
In addition to the information collected during the
follow-up interview, we explored the possibility of
extracting additional information through linkage with
existing databases storing routinely collected data on
patients’ use of medication, consultations, and other
treatments related to their mental health. As our aim
was to collect information on the costs of the inter-
vention, we excluded ‘sunk’ costs, such as develop-
ment of the depression programme’s media resources,
which would not recur in practice. We also excluded
the costs of the initial identification and screening of
patients. We assumed that in practice NAs/CHWs
would conduct PHQ-9 screening as part of their rou-
tine regular home visits with elderly patients. We also
excluded costs incurred equally in both arms of the
study (such as training of family doctors and nurses).
The running costs of the intervention include: the
equipment and support costs for the Information
Technology system (IT); the costs of training NAs/
CHWs in intervention delivery; intervention delivery
costs; and the costs of supervising NAs/CHWs.
The psychosocial intervention
The intervention developed is aligned with the princi-
ples of collaborative and stepped-care, and with
considerable task-shifting involved. One of the main
goals of the intervention is to strengthen the auton-
omy of the patients and highlight the role they have
to play for their own improvement. Participants
should be able to, slowly, turn the vicious cycle of
depression into a virtuous cycle of recovering from
depression. The intervention consisted of a unique
blend of psychosocial techniques tailored according to
the needs of each participant and with embedded
support mechanisms for non-specialist health workers
delivering the intervention. The main theoretical
orientation is that of behavioural activation (BA) in
view of its demonstrated feasibility and efficacy for
the treatment of depression [37, 38]. A recent non-in-
feriority and cost-effectiveness study (COBRA-trial)
comparing both BA and Cognitive Behavioural Ther-
apy (CBT) for depression showed that behavioural
activation can be delivered by junior mental health
workers with no lesser effect and at less cost than
CBT [39]. Recent meta-analyses have demonstrated its
effectiveness in treating older adults with depression
[37, 38], with improvement rates similar to those
achieved through medication and often preferred by
the elderly [18, 19]. It is a simple technique to apply
and requires only a short period of professional train-
ing [40, 41]. Briefly, behavioural activation promotes
the engagement in pleasant activities, which increases
positive interactions with their environment. Behav-
ioural activation is eminently suitable for delivery by
non-specialists [40, 42, 43]. Furthermore, the inter-
vention incorporates elements of psychoeducation
(that is, education about depression and simple cop-
ing strategies to deal with depressive symptoms and
associated problems), and relapse prevention (that is,
simple strategies to remain euthymic). There is con-
tinuous monitoring of depressive symptoms with the
use of the PHQ-9 depression scale and management
for other chronic health problems.
The intervention itself is divided into Initial (3 weeks)
and Second (14 weeks) Phases (Fig. 1). Home sessions
were face to face and lasted approximately 60 min (for
detailed information, see Table 3).
Initial phase
All participants complete the Initial Phase, which in-
cludes three weekly meetings. The goal of this phase is
to provide psychoeducation about depression and de-
velop, along with the patient, simple strategies to deal
with depressive symptoms. In all sessions, NAs/CHWs
measure depression symptoms and enquire about a list
of common chronic physical conditions. If any chronic
physical condition is present, NAs/CHWs check if these
are under active control and the level of adherence to
medications, if prescribed.
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Second phase
During the Second Phase, participants access either low
or high intensity regimes. If the patient has improved
sufficiently after the Initial Phase (PHQ-9 < 10 in both
Session 2 and 3), they proceed to the Second Phase, low
intensity regime, which includes five additional meetings
(3 biweekly and 2 monthly). If the patient does not im-
prove sufficiently (PHQ-9 ≥ 10 in Session 2 and/or Ses-
sion 3), they are referred to the high intensity regime
that includes eight additional meetings (6 weekly and 2
monthly). The intervention lasts for 17 weeks in total,
regardless of the regime. The goal of the programme’s
Second Phase is to teach patients behavioural activation
and relapse prevention techniques. The focus of care is
thus on increasing patient involvement in pleasant activ-
ities, on reducing avoidant or excessive behaviours asso-
ciated with symptoms of depression, and on
strengthening the ability of the patient to identify and
deal with symptoms of depression.
The intervention was designed to be delivered by NAs
or CHWs. We chose these health workers to deliver the
intervention because they are part of the FHT, visit
Fig. 1 The Psychosocial Intervention Flow
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homes regularly, and are involved in the care of chronic
conditions. Delivery at home was selected for several
reasons: older adults have difficulties travelling, an inter-
vention at home is likely to improve adherence, the
CHWs visit homes at least monthly and NAs make visits
whenever it is needed, and because it provides an oppor-
tunity to assess the home environment and to contact
carers, if available. Health workers were supported
through a specially designed technological platform, and
continuous supervision delivered by psychologists.
The technological platform contained a tablet applica-
tion that included: (a) the structure of each session to
guide the NA/CHW during the intervention. This struc-
ture is adapted to the specific needs of the participant as
identified during the session (for example, an extra ques-
tionnaire in case of suicidality, homework tailored to
problems identified during the session) and as deter-
mined by the severity of depressive symptoms in the ini-
tial phase of the intervention; (b) a function to schedule
appointments with the participant, keep track of missed
or moved appointments; (c) graphs with mood ratings,
adherence to homework, and algorithms that activate
notification to various stakeholders (such as NAs/
CHWs, managers, clinical supervisor); (d) a structured
approach for choosing, planning, and assessing adher-
ence to homework; (e) an automated notification system
to warn the clinic manager about the need to discuss
participants who did not improve or showed high sui-
cidal risk, the attendance of those delivering the inter-
vention to supervision, and/or delays in delivering
sessions; and (f) a function for audio recording of ses-
sions for use in supervision if needed. The tablet applica-
tion is enriched with media resources created
collaboratively between media professionals and the re-
search team. Twenty-three animated short videos were
developed, highlighting all the main contents of the
intervention. Three animated characters were created to
portray, respectively, a person adherent to treatment, a
participant with some problems with adherence, and the
health care provider. The technological platform also
stores participant data collected during assessments and
sessions, and allows access to this dataset through tablets
or computers. Web interfaces were created to allow
monitoring of participant progress in the trial by the re-
search team – for instance, inclusion of participants in
the trial, start date of the intervention, number of ses-
sions completed and follow-up date.
Enhanced usual care
Participants included in the intervention and control
arms of the pilot study received ‘enhanced usual care’,
adding (1) identification of depression and (2) additional
training of nurses and family doctors to the usual care.
The FHT was responsible for delivering usual care for
both the control and intervention clinics in the study.
Briefly, usual care in clinics is carried out through con-
sultations with nurses and/or family doctors. Whenever
needed, NAs, nurses or family doctors might visit pa-
tients at home. In general, households registered with
the clinic receive a monthly visit from CHWs. Face-to-
face consultations at the clinic also take place, if needed.
Health professionals assess each case and either initiate
treatment or refer patients to more specialized health
care professionals. When patients are referred to special-
ized care, they continue to be seen by the team simul-
taneously to ensure continuity of care. Regarding mental
health, the clinic usually relies on support from the Fam-
ily Support Team (NASF in Portuguese), which includes
psychologists, nutritionists, physiotherapists, speech
therapists, occupational therapists, and psychiatrists. If
patients need to be seen by specialized mental health
care professionals, they can be referred to psychiatrists
and psychologists at the Psychosocial Care Centres
(CAPS in Portuguese).
Training
We developed treatment protocols to cover the require-
ments of non-specialist health workers delivering the
intervention. These health workers participated in a
training programme and received continuous group
supervision. The training programme consisted of three
full days of training delivered by two research psycholo-
gists. The training included an overview of the interven-
tion, discussion about depression and its treatment in
older adults, specific session contents, psychosocial tech-
niques to deliver the intervention, ways to engage with
patients, and how to use the technological support plat-
form. The continuous group supervision (up to six
health workers in each group) was delivered by a re-
search psychologist and included discussion of cases and
review of session contents. Initially the group supervi-
sion was weekly and then biweekly, when sessions be-
came less frequent.
Nurses and family doctors in both arms received a
brief training session before the pilot study started. A
psychiatrist and a member of the research group deliv-
ered the training in each clinic. It consisted of a 90-min
lecture about depression and depression care for elderly
patients, medication management, followed by an ap-
proximately one-hour discussion about the pilot study
protocol. In the intervention clinic, the discussion was
about how cases of depression would be identified by
the research team and referred to the intervention, and
about the core principles of the intervention (collabora-
tive, stepped-care, and task-shifting). It was also an-
nounced that an on-call psychiatrist would be available
to provide advice about the treatment of patients in-
cluded in the pilot study, and how they could contact
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this psychiatrist (initially by email). In the control clinic,
we explained that after identification of cases of depres-
sion by the research team, a list with the names of all pa-
tients with depression from their clinic included in the
study would be sent to the clinic’s manager, who would
be responsible for informing the team. After this, the
team professionals would be responsible for the manage-
ment of these cases as in usual care.
Data analysis
For the purposes of the pilot study, the analyses utilized
just descriptive statistics such as frequencies, propor-
tions/percentages, means and standard deviations (SD).
Given our aims and that numbers in this pilot study
were too small for reliable inferences, between-group
comparisons of outcomes are not appropriate. This
manuscript adheres to CONSORT guidelines.
Results
Aim 1. To assess the feasibility of recruitment,
assessments, and random selection of participants
In the intervention arm, CHWs for the seven FHTs pro-
vided details of 2020 individuals. To reflect our plans for
the definitive trial given the sample size requirements
detailed below, we then sampled at random 579 individ-
uals (28.7%) for potential inclusion (Fig. 2). Of these 579,
PHQ-9 scores were obtained for 353 (61.0%), of whom
40 (11.0%) scored at least 10. Of these 40, 33 (82.0%)
consented to enter the pilot – which corresponds to a
yield of 5.7% of the original 579 sampled. In the control
arm, CHWs of the three FHTs provided details for 1482
individuals, we sampled at random 320 (21.6%), and
PHQ-9 scores were obtained for 223 (69.7%). Among
the 28 (12.6%) participants with PHQ-9 ≥ 10, 25 (89.0%)
consented to participate in the study, with a resulting
yield of 25/320 (7.8%). The age and sex distributions be-
tween those sampled and recruited were similar in both
arms; however, in the intervention arm there was a mar-
ginal over-representation of females and individuals 70
or more years old amongst those recruited (data not
shown). Overall, 58 out of 68 eligible individuals (85.0%)
consented, producing a yield of 58 (6.5%) out of 899
sampled across the two clinics. Recruitment started in
October 2015 and ended in December 2015.
The characteristics of recruited individuals in both
arms are given in Table 1. There were very few missing
values for any of the variables among those sampled for
inclusion. It is also worth noting that, while the baseline
mean PHQ-9 score was slightly lower in the control
than the intervention clinic (13.9 and 15.5 respectively),
the standard deviations were very similar between these
two clinics (Table 1).
In terms of the follow-up, 23 out of 25 (92%) in the
control, and 31 out of 33 (94%) in the intervention arm
provided a score on depression (PHQ-9) at 26-weeks
post-recruitment (Table 2). It can be seen that (albeit
with small numbers) for all measures (PHQ-9, EQ-5D-5
L, and ICECAP-O), the intervention group commences
with poorer results and ends with similar or slightly bet-
ter outcomes in comparison with the control group
(Table 2). As stated earlier, formal comparisons are not
appropriate given the aims and the design of the pilot
study (including the small numbers), but this is at least
encouraging and the general lessons that were learnt
from these data will be covered in the discussion. Other
characteristics of participants, such as physical incap-
acity, social support, stressful life events, use of alcohol
and tobacco were successfully collected in both arms of
the study (results not shown), supporting the feasibility
of collecting this type of data with this population. We
did not identify any harm or unintended effects in par-
ticipants of both arms of the pilot trial.
Aim 2. To obtain an estimate of the outcome variance
and recruitment/retention rates to inform sample size
calculations for the definitive RCT
A sample size calculation based on the information col-
lected in this pilot study (the intra-cluster correlation
coefficient of 0.03 used to calculate the sample size was
based on our previous study43 and on the literature)
showed that the definitive RCT would require 20 clinics
(clusters), with the inclusion of 1440 depressed older
adults to detect a 15-percentage point difference in the
primary outcome with 86.5% power and 15% attrition. If
the 7% attrition rate found in the pilot pertained in the
definitive trial, then we would have a power of approxi-
mately 90% to detect the target difference of 15%.
During this pilot study, we identified that there are on
average 400 individuals in the eligible age range regis-
tered with each FHT (data not shown), and therefore 40
individuals potentially eligible (assuming 10% prevalence
of depression). We are likely to have 24 individuals per
team once the entry criteria are applied (approximately
6% of the total). The experience from the pilot indicates
that we should work with four teams per clinic, three
CHWs per team, and that each CHW can manage at
least three participants at any given time. For this rea-
son, we will only recruit 18 of these 24 individuals and
plan to conduct the RCT in two waves. In each wave, a
total of 36 individuals per clinic (cluster) will be
included.
Aim 3. To evaluate the feasibility of delivering the
psychosocial intervention, and to compare the
performance of community health workers (CHWs) and
nurse assistants (NAs) delivering the intervention
Regarding the process of delivering the intervention,
Fig. 3 shows that of the 33 individuals who consented,
Scazufca et al. BMC Public Health         (2019) 19:1152 Page 7 of 14
five withdrew from the intervention during the initial
phase (the first three sessions). Of the 28 who proceeded
to the second phase, 15 (54.0%) followed the low inten-
sity and 13 the high intensity route. Of these two groups,
13 (87.0%) and six (46.0%) completed all of the intended
sessions respectively. However, three individuals did not
complete the session simply due to the slightly curtailed
time available for the follow-up in the pilot study – the
time limit for completing the intervention was 24 weeks
after patients were assigned to health workers (Fig. 3).
Three NAs (from three FHTs) and eight CHWs (from
four FHTs) delivered the intervention. Comparing the
NA-managed participants with those managed by
CHWs, the completion rate was higher for the former
(8/9, 88.9%, and 11/24, 45.8%) but numbers were very
small and all but one of the high intensity participants
were in the CHWs’ group. Considering the low intensity
group only, the percentages completing were 100% (7/7)
and 75% (6/8) for the NA and CHW group respectively.
While these involve very small numbers, no noticeable
differences between the health workers’ groups are sug-
gested from these figures.
Approximately 94% of the CHWs and NAs attended
each of the 3 days training. The group supervision was
also well attended by CHWs and NAs (approximately
85% attendance on each day). As the supervision pro-
gressed, we found that CHWs/NAs needed technical
support between sessions, mostly due to issues regarding
Fig. 2 CONSORT flow diagram of the pilot study
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the tablet application. Therefore, the supervisors created
a WhatsApp network to deal with these issues. The
training programmes conducted in the intervention and
control clinics were well attended by nurses and family
doctors. The psychiatrist on-call was never contacted by
the nurses or family doctors from the intervention clinic,
despite repeated reminders sent to the teams after the
initial training that this resource was available.
Aim 4. To assess the feasibility of collecting information
on use of resources, including costs associated with
intervention delivery, and health data from existing
health system databases, to conduct an economic
evaluation during the definitive trial
Regarding the feasibility of collecting health data from
health system databases, we found that while it was theor-
etically possible to link to routinely collected electronic
health systems data, we were unable to implement an au-
tomated method of extracting data from these systems.
Data extracted from the health system databases suggested
that there were no substantial differences in terms of
prescribing antidepressant medication in the intervention
and control groups during the study.
The IT equipment costs during the pilot involved a Per-
sonal Computer server hosted within the University of
São Paulo service. For a larger roll out of the system, the
IT resources would include a more powerful server in-
cluding redundancy, data backup, power supply and soft-
ware licensing. In addition, tablets, SIM cards and
keyboards are needed for the health workers delivering
the intervention. The cost of trainee and trainer time in-
cludes a three-day training course for health workers be-
fore the start of the psychosocial intervention, and
supervisory group sessions during the intervention period.
All of these costs are fixed or semi-fixed costs that do not
increase linearly with the number of patients treated. If
only CHWs delivered the intervention, the intervention
cost per patient (excluding the fixed and semi-fixed costs
described above) would be approximately US$25.22 in the
low intensity group and US$34.68 in the high intensity
group (Table 3). If NAs delivered the intervention, these
costs would be 65% higher.
Table 1 Characteristics of the individuals in both arms of the pilot
Variables Categories Control
(n = 25)
Intervention
(n = 33)
Total
(N = 58)
Age 60–64 24% 9% 15%
65–69 16% 27% 22%
> = 70 60% 64% 62%
Sex Female 80% 73% 76%
Male 20% 27% 24%
Education (in years) < 5 64% 73% 69%
> = 5 36% 27% 31%
Personal incomea
(Brazilian minimum wage units, US$288.30) b
<=2 84% 94% 89%
> 2 4% 6% 5%
PHQ-9 (baseline) Mean (SD) 13.9 (3.7) 15.5 (3.5) 14.8 (3.6)
a3 missing cases in the control group
bExchange rate US$/Real (1US$ = R$3,25)
Table 2 Patient Health Questionnaire-9 (PHQ-9), European Quality of Life 5 Dimensions-5 levels version (EQ-5D-5 L), and
Investigating Choice Experiments for the Preferences of Older People-CAPability (ICECAP-O) [Mean (SD)] at baseline and follow-up
for the control and intervention arms
Measure Time
Point
Control Intervention Total
N M (SD) N M (SD) N M (SD)
PHQ-9 Baseline 25 13.9 (3.7) 33 15.5 (3.5) 58 14.8 (3.6)
Follow-up 23 12.3 (3.7) 31 3.8 (3.9) 54 7.4 (5.7)
EQ-5D-5 La Baseline 25 0.8081 (0.13) 33 0.7127 (0.16) 58 0.7539 (0.15)
Follow-up 23 0.8202 (0.13) 31 0.8121 (0.14) 54 0.8156 (0.14)
ICECAP-O Baseline 3b 0.6631 (0.14) 33 0.5564 (0.18) 36 0.5653 (0.18)
Follow-up 23 0.7067 (0.15) 30 0.7328 (0.16) 53 0.7214 (0.15)
aEQ-5D-5 L and ICECAP-O higher scores represent better outcomes
bThe ICECAP-O was administered only to a few participants in the control group at baseline because we were initially uncertain of its feasibility for people with
low levels of literacy. After testing the questionnaire and concluding that participants could provide a valid response to the ICECAP-O, we collected baseline
information with 3 control and all intervention participants
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Discussion
This pilot study aimed to assess the feasibility of under-
taking a definitive RCT of a psychosocial intervention
targeting depression improvement among older adults.
Low levels of refusal at recruitment, few exclusions when
applying our exclusion criteria, high levels of consent
(over 80%) among eligible participants in both arms, and
low levels of attrition at follow-up, confirms that it is
feasible to conduct the definitive RCT, and that the trial
is likely to provide statistically precise information.
Task-shifting proved to be feasible, including delivery
through the home visits by CHWs.
The pilot did identify difficulties in contacting poten-
tially eligible individuals. We noticed that the lists pro-
vided by the CHWs were out-of-date – specifically, they
included individuals who were not contactable because
they had moved to another area. Some eligible partici-
pants were not contacted because they were not at home
when the research team tried to contact them. For the
definitive trial, the research team will obtain the lists of
patients directly from the clinic electronic systems and
hence the overall number of older adults registered with
the clinic will be much closer to the real total and the
contact data will be much more up-to-date. Additionally,
in the definitive RCT, we are planning to carry out two
waves of recruitment so that those older adults uncon-
tactable in the first wave might be reached and included
in the second wave.
Ideally, allocation of participants should consider the
individual level of depression at baseline, as its severity
Fig. 3 Flow diagram of the intervention arm
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is known to be a good predictor of depression recovery
[44–46]; this is usually achieved by stratification by a
summary measure at the cluster level. Such data will not
be available in advance for a definitive trial. However, we
will collect individual data on severity of depression at
baseline as well as follow-up and hence we will be able
to adjust for the former in the relevant (primary) analysis
– mainly to maximize power in the context of a cluster
randomized trial [47]. Rather than restricting the alloca-
tion according to baseline depression in the definitive
RCT, we will use available sociodemographic data to
make sure the two groups of clusters (clinics) are as bal-
anced as possible. We will utilise census data on educa-
tional levels (of the head of the household) for the
relevant census district to stratify the (cluster) random-
isation and hence avoid the imbalance on some socio-
demographic variables that was arguably inevitable in
this small pilot. In the definitive RCT, we aim to include
20 clinics, 72 depressed older adults in each of the two
groups of clinics, giving a total of 1440 participants.
Any difference observed in the levels of the primary
(PHQ-9) and other outcomes was not an important issue
in the pilot study given that the purpose was not to
make between arm comparisons, but to learn about
feasibility of intervention and procedures. It is nonethe-
less worth noting that, in the pilot study, the mean
PHQ-9 at follow-up in the intervention clinic was very
much lower than at baseline. This observation indicates
that the intervention is not only feasible but is also
promising in terms of its effectiveness albeit in the con-
text of a small pilot study where many of the key proce-
dures were being developed and assessed.
Overall, out of the 33 participants who consented
within the intervention arm of the pilot study, 28 (85%)
completed the Initial Phase of the intervention (3 ses-
sions), 19 (59.6%) completed all sessions of the interven-
tion (8 or 11 sessions) and only one participant
withdrew from the intervention before the first session,
indicating good adherence to the intervention. Although
the focus of the intervention is the treatment of depres-
sion, we observed during the pilot study that asking
patients about other chronic conditions increased adher-
ence to the intervention, possibly because patients felt
that their health problems were being treated
comprehensively.
Task-shifting challenges are not only related to pa-
tients’ acceptance of non-specialist advice, but also the
ability of CHWs to adjust to their new role. To support
the delivery of the intervention, we developed a tablet
application with the structure of the sessions and con-
siderable media resources available to support the activ-
ities carried out during sessions. Another challenge was
related to collaborative care (that is, discussing cases
with the health team). The knowledge acquired during
sessions, the supervision, and the notification system
embedded within the app empowered health workers to
overcome usual communication barriers with more spe-
cialized professionals. Some health workers saw patients
who were registered with the clinic but with another
health worker. Health professionals and patients did not
object to this. Our findings showed that the CHWs and
NAs were well supported by health teams in so far as
this programme is concerned. Lastly, bearing in mind
that there do not appear to be substantial differences in
delivery between CHWs and NAs, the lower costs asso-
ciated with CHWs and the considerably lower disruption
to the provision of other services in the clinics, suggest
that CHWs are a good choice to deliver the
intervention.
The pilot study suggested modifications to the training
programme conducted with nurses and family doctors of
the control and intervention clinics. Professionals work-
ing in the Family Health Strategy received training on
how to treat and manage patients with depression, but
we found no noticeable differences in this respect across
clinics. For this reason, we decided to exclude this aspect
of the training, as it would add extra costs to the
programme with potentially little benefit. Also, as the
on-call psychiatrist available for the intervention clinic
was never contacted, we also decided that it was un-
necessary. However, we did observe during the pilot
study that the training given to the nurses and doctors
Table 3 Cost of the psychosocial intervention per patient
Low intensity High intensity
Intervention
Average duration of session (minutes) 52 52
Number of sessions 8 11
CHW wage per month (including tax and benefits)a US$ 640.64 US 640.64
CHW days worked per month 22 22
CHW hours worked per day 8 8
CHW wage per hour US$ 3.64 US$ 3.64
Cost of intervention (if all sessions attended) per patient US$ 25.22 US$ 34.68
aExchange rate US$/Real (1US$ = R$3.25)
Scazufca et al. BMC Public Health         (2019) 19:1152 Page 11 of 14
from the intervention clinic seemed to have improved
communication within the family health team and led to
obtaining a swifter response from family doctors when
there was a need to discuss patients. As a consequence,
we decided to train all team members (nursing assis-
tants, nurses, family doctors and the community health
workers) from the intervention arm on improving team
communication, an essential aspect of collaborative care,
and not only with nurses and family doctors.
Whilst we are investigating if an automated method of
extracting data from health system databases is technic-
ally feasible for the definitive RCT, we will consider
whether it would be more feasible to collect key items of
health care use (such as antidepressant medications) dir-
ectly from patients. An economic evaluation alongside
the definitive trial could estimate the trade-off between
intervention costs, any subsequent increases or decreases
in healthcare costs and improved outcomes measured by
the EQ-5D-5 L, ICECAP-O, and PHQ-9. The cost esti-
mations reported in this paper suggest that the interven-
tion is affordable, but they are preliminary as the
number of participants is small. In a definitive RCT, cost
data might be expanded, for instance to include the in-
direct costs of depression due to time off work or usual
activities.
This pilot study provided evidence in favour of the
feasibility of a definitive RCT of this psychosocial inter-
vention targeting depression improvement in older
adults. In Brazil, as in other LMICs, there is a gap with
respect to integrating mental health into primary care
services. This gap is even more pronounced when it
comes to depression in late life. Therefore, a pragmatic
trial focusing on improving identification and treatment
of depression in older adults in primary care is urgently
needed. A positive outcome may constitute a timely con-
tribution to evidence-based treatment options for de-
pressed older adults and reduce health costs and
dependency on specialized mental health resources, a
problem encountered in most LMICs. This study is reg-
istered with Registro Brasileiro de Ensaios Clínicos
(ReBEC), number RBR-5nf6wd.
Conclusions
In this pilot study we assessed the feasibility of recruit-
ment, assessments, randomization as well as other pro-
cedures to conduct a cluster randomized controlled trial
of an intervention to treat depressed elderly people liv-
ing in socio-economically deprived areas of Sao Paulo.
Recruitment, assessments, randomization as well as most
other procedures (Aim 1) were found to be highly feas-
ible within this setting. We were also able to ascertain
some essential parameters to estimate the sample size as
well as retention rates (Aim 2), both of which proved to
be auspicious. We also found it feasible to deliver the
intervention in primary care clinics and the two types of
health workers that were trained (NAs and CHWs)
could equally deliver the intervention (Aim 3). We inves-
tigated the possibility of collecting cost-related informa-
tion associated with the intervention delivery, and health
data from existing health system databases (Aim 4). Our
preliminary results suggest that routinely collected data
is still not sufficiently reliable or complete to conduct a
proper cost-effectiveness analysis. Thus, we will collect
most of the cost data as part of the research component
when we start the fully powered RCT. In Brazil, as in
other LMICs, there is a gap with respect to integrating
mental health into primary care services. This gap is
even more pronounced when it comes to depression in
late life. Therefore, a pragmatic trial focusing on improv-
ing identification and treatment of depression in older
adults in primary care is urgently needed.
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